[Contrast density and side effect rate in lumbar myelography--a clinical comparison of Meglumin-Iocarmate and Metrizamide].
The author reports that side effects were somewhat more frequent after metrizamide than after meglumin-iocarmate, in the course of a comparative study carried out at the reporting hospital from the beginning of 1977, using the water-soluble x-ray contrast media Amipaque (metrizamide) and Dimer X (meglumin-iocarmate).